DAP:ETR
Danaher Corp
€204.70
arrow_downward
-0.49%(-1.00) 1D
Nov 6, 5:35:52 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
€201.60
High
€204.70
Low
€198.45
Mkt. cap
161.99B
Avg. vol.
567.00
Volume
1.43K
52-wk high
€214.50
52-wk low
€138.20
No. of employees
59K
Open
€201.60
High
€204.70
Low
€198.45
Mkt. cap
161.99B
Avg. vol.
567.00
Volume
1.43K
52-wk high
€214.50
52-wk low
€138.20
No. of employees
59K
News stories
From web sources and news partners
CryptoPotato
·
10 minutes ago
We Are Still Early: One Brutal Wall Street Session Erased More Than the Entire Crypto Market
Traders Union
·
33 minutes ago
Brad Gerstner: $1,000 invested for each child born in auto-created U.S. Treasury S&P 500 accounts
شبكة تواصل الإخبارية
·
54 minutes ago
Democrats Just Swept Congress. Here's What History Says the S&P 500 Does Next.
www.tmgm.com
·
18 hours ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp